Compounds > arg-3-hyp-7-phe-bradykinin
Page last updated: 2024-09-03

arg-3-hyp-7-phe-bradykinin and n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide

arg-3-hyp-7-phe-bradykinin has been researched along with n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide in 1 studies

Compound Research Comparison

Studies
(arg-3-hyp-7-phe-bradykinin)		Trials
(arg-3-hyp-7-phe-bradykinin)		Recent Studies (post-2010)
(arg-3-hyp-7-phe-bradykinin)		Studies
(n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide)		Trials
(n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide)		Recent Studies (post-2010) (n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide)
52231,2203229

Protein Interaction Comparison

ProteinTaxonomyarg-3-hyp-7-phe-bradykinin (IC50)n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide (IC50)
Prostaglandin E synthaseHomo sapiens (human)10
Prostaglandin G/H synthase 1Ovis aries (sheep)2.1
AromataseHomo sapiens (human)0.68
Prostaglandin G/H synthase 1Mus musculus (house mouse)1.67
Prostaglandin G/H synthase 1Homo sapiens (human)3
Prostaglandin G/H synthase 2Homo sapiens (human)0.9037
Prostaglandin G/H synthase 2Ovis aries (sheep)2.4333
Prostaglandin G/H synthase 2Mus musculus (house mouse)0.1522
Carboxypeptidase B2Homo sapiens (human)1.8
Prostaglandin E synthaseMus musculus (house mouse)0.007

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Axe, FU; Bembenek, SD; Butler, CR; Coles, F; Dunford, PJ; Edwards, JP; Fourie, AM; Grice, CA; Karlsson, L; Lundeen, K; Riley, JP; Savall, BM; Tays, KL; Wei, J; Williams, KN; Xue, X1

Other Studies

1 other study(ies) available for arg-3-hyp-7-phe-bradykinin and n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide

ArticleYear
Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity.
    Journal of medicinal chemistry, 2008, Jul-24, Volume: 51, Issue:14

    Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Catalysis; Dogs; Drug Evaluation, Preclinical; Enzyme Inhibitors; Epoxide Hydrolases; Humans; Magnetic Resonance Spectroscopy; Mice; Structure-Activity Relationship

2008